-
公开(公告)号:JP2001199954A
公开(公告)日:2001-07-24
申请号:JP2000366579
申请日:2000-12-01
Applicant: MERCK FROSST CANADA INC
Inventor: BELLEY MICHEL , GAUTHIER JACQUES Y , ERICH GRIMM , LEBLANC YVES , CHUNG-SING LI , THERIEN MICHEL , BLACK CAMERON , CHEUK-KUN LAU , PETPIBOON PRASIT , ROY PATRICK
IPC: C07D333/06 , A61K31/12 , A61K31/122 , A61K31/34 , A61K31/341 , A61K31/343 , A61K31/38 , A61K31/381 , A61K31/404 , A61K31/4184 , A61K31/4196 , A61K31/425 , A61K31/429 , A61K31/433 , A61K31/435 , A61K31/4355 , A61K31/437 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/47 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/54 , A61P25/04 , A61P29/00 , A61P43/00 , C07C317/24 , C07D213/64 , C07D307/58 , C07D307/60 , C07D307/62 , C07D307/64 , C07D307/66 , C07D307/68 , C07D307/83 , C07D307/94 , C07D333/26 , C07D405/12 , C07D407/12 , C07D409/12 , C07D417/12 , C07D471/04 , C07D491/04 , C07D491/048 , C07D495/04 , C07D498/04 , C07D513/04
Abstract: PROBLEM TO BE SOLVED: To provide a new compound useful for treating cyclooxygenase-2- mediated diseases. SOLUTION: The compound represented by formula (I), and the medicinal composition for treating cyclooxygenase-2-mediated diseases, such as inflammatory diseases. Concretely, the compound of formula (II) is exemplified.
-
公开(公告)号:CA2503767C
公开(公告)日:2009-09-22
申请号:CA2503767
申请日:2003-10-28
Applicant: MERCK FROSST CANADA INC
Inventor: LEBLANC YVES , ROY PATRICK , DUFRESNE CLAUDE
IPC: C07D471/14 , A61K31/4375 , A61K31/4745 , A61P11/00 , A61P29/00
Abstract: Pyridopyrrolizine and pyridoindolizine derivatives are prostaglandin recepto r antagonists useful for the treatment of prostaglandin-mediated diseases such as allergic rhinitis, nasal congestion and asthma.
-
公开(公告)号:CZ295764B6
公开(公告)日:2005-10-12
申请号:CZ110198
申请日:1996-10-09
Applicant: MERCK FROSST CANADA INC
Inventor: BELLEY MICHEL , GAUTHIER JACQUES Y , GRIMM ERICH , LEBLANC YVES , LI CHUNG-SING , THERIEN MICHEL , BLACK CAMERON , LAU CHEUK-KUN , PRASIT PETPIBOON , ROY PATRICK
IPC: C07D333/06 , A61K31/12 , A61K31/122 , A61K31/34 , A61K31/341 , A61K31/343 , A61K31/38 , A61K31/381 , A61K31/404 , A61K31/4184 , A61K31/4196 , A61K31/425 , A61K31/429 , A61K31/433 , A61K31/435 , A61K31/4355 , A61K31/437 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/47 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/54 , A61P25/04 , A61P29/00 , A61P43/00 , C07C317/24 , C07D213/64 , C07D307/58 , C07D307/60 , C07D307/62 , C07D307/64 , C07D307/66 , C07D307/68 , C07D307/83 , C07D307/94 , C07D333/26 , C07D405/12 , C07D407/12 , C07D409/12 , C07D417/12 , C07D471/04 , C07D491/04 , C07D491/048 , C07D495/04 , C07D498/04 , C07D513/04 , A61K31/365 , A61K31/58
Abstract: The present invention relates to (Methylsulfonyl)phenyl-2-(5h)-furanone derivatives of the general formula I, in which the individual general symbols are as specified in the main Claim, wherein these derivatives are effective inhibitors of cyclooxygenase, exhibit antiphlogistic activity and therefore they can be used for the preparation of a pharmaceutical composition forming a part of the present invention, too and having the above-indicated effect.
-
公开(公告)号:BR0315681A
公开(公告)日:2005-09-06
申请号:BR0315681
申请日:2003-10-28
Applicant: MERCK FROSST CANADA INC
Inventor: LEBLANC YVES , DUFRESNE CLAUDE , ROY PATRICK
IPC: A61K31/4745 , A61P11/00 , A61P29/00 , C07D471/14 , A61K31/4375
Abstract: Pyridopyrrolizine and pyridoindolizine derivatives are prostaglandin receptor antagonists useful for the treatment of prostaglandin-mediated diseases such as allergic rhinitis, nasal congestion and asthma.
-
公开(公告)号:NO20052591A
公开(公告)日:2005-07-29
申请号:NO20052591
申请日:2005-05-27
Applicant: MERCK FROSST CANADA INC
Inventor: LEBLANC YVES , ROY PATRICK , DUFRESNE CLAUDE
IPC: A61K31/4745 , A61P11/00 , A61P29/00 , C07D471/14 , A61K31/4375
CPC classification number: C07D471/14
-
公开(公告)号:DE122005000010I1
公开(公告)日:2005-06-23
申请号:DE122005000010
申请日:1996-10-09
Applicant: MERCK FROSST CANADA INC
Inventor: BELLEY MICHEL , GAUTHIER JACQUES Y , GRIMM ERICH , LEBLANC YVES , LI CHUNG SING , THERIEN MICHEL , BLACK CAMERON , LAU CHEUK KUN , PRASIT PETPIBOON , ROY PATRICK
IPC: C07D333/06 , A61K31/12 , A61K31/122 , A61K31/34 , A61K31/341 , A61K31/343 , A61K31/38 , A61K31/381 , A61K31/404 , A61K31/4184 , A61K31/4196 , A61K31/425 , A61K31/429 , A61K31/433 , A61K31/435 , A61K31/4355 , A61K31/437 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/47 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/54 , A61P25/04 , A61P29/00 , A61P43/00 , C07C317/24 , C07D213/64 , C07D307/58 , C07D307/60 , C07D307/62 , C07D307/64 , C07D307/66 , C07D307/68 , C07D307/83 , C07D307/94 , C07D333/26 , C07D405/12 , C07D407/12 , C07D409/12 , C07D417/12 , C07D471/04 , C07D491/04 , C07D491/048 , C07D495/04 , C07D498/04 , C07D513/04
Abstract: The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).
-
公开(公告)号:NO20052591D0
公开(公告)日:2005-05-27
申请号:NO20052591
申请日:2005-05-27
Applicant: MERCK FROSST CANADA INC
Inventor: LEBLANC YVES , ROY PATRICK , DUFRESNE CLAUDE
IPC: A61K31/4745 , A61P11/00 , A61P29/00 , C07D471/14 , C07D
Abstract: Pyridopyrrolizine and pyridoindolizine derivatives are prostaglandin receptor antagonists useful for the treatment of prostaglandin-mediated diseases such as allergic rhinitis, nasal congestion and asthma.
-
公开(公告)号:AU761596B2
公开(公告)日:2003-06-05
申请号:AU5724199
申请日:1999-09-21
Applicant: MERCK FROSST CANADA INC
Inventor: LEBLANC YVES , DUFRESNE CLAUDE , WANG ZHAOYIN , LI CHUN SING , GAUTHIER JACQUES Y , THERIEN MICHEL , LAU CHEUK K , ROY PATRICK
IPC: A61K45/00 , A61K31/66 , A61K31/662 , A61K31/663 , A61P3/04 , A61P3/10 , A61P43/00 , C07F9/38 , C07F9/553 , C07F9/6506 , C07F9/6518 , C07F9/6524 , C07F9/653 , C07F9/6539 , C07F9/6541 , H04L12/56 , H04M3/00 , H04M3/42 , H04Q3/62
-
公开(公告)号:SK282639B6
公开(公告)日:2002-10-08
申请号:SK45098
申请日:1996-10-09
Applicant: MERCK FROSST CANADA INC
Inventor: BELLEY MICHEL , GAUTHIER JACQUES Y , GRIMM ERICH , LEBLANC YVES , LI CHUNG-SING , THERIEN MICHEL , BLACK CAMERON , LAU CHEUK-KUN , PRASIT PETPIBOON , ROY PATRICK , GAUTHIER JACQUES YVES
IPC: C07D333/06 , A61K31/12 , A61K31/122 , A61K31/34 , A61K31/341 , A61K31/343 , A61K31/38 , A61K31/381 , A61K31/404 , A61K31/4184 , A61K31/4196 , A61K31/425 , A61K31/429 , A61K31/433 , A61K31/435 , A61K31/4355 , A61K31/437 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/47 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/54 , A61P25/04 , A61P29/00 , A61P43/00 , C07C317/24 , C07D213/64 , C07D307/58 , C07D307/60 , C07D307/62 , C07D307/64 , C07D307/66 , C07D307/68 , C07D307/83 , C07D307/94 , C07D333/26 , C07D405/12 , C07D407/12 , C07D409/12 , C07D417/12 , C07D471/04 , C07D491/04 , C07D491/048 , C07D495/04 , C07D498/04 , C07D513/04 , A61K31/365
Abstract: Disclosed are (methylsulphonyl)phenyl-2-(5H)-furanone derivatives of general formula (I). They are effective inhibitors of cyclooxygenase with anti-inflammatory effect and it is possible to use them for production of pharmaceutical preparation with the said effect, which is also a part of the invention.
-
公开(公告)号:BG63391B1
公开(公告)日:2001-12-31
申请号:BG10242598
申请日:1998-05-04
Applicant: MERCK FROSST CANADA INC
Inventor: BELLEY MICHEL , GAUTHIER JACQUES Y , GRIMM ERICH , LEBLANC YVES , LI CHUNG-SING , THERIEN MICHEL , BLACK CAMERON , LAU CHEUK-KUN , PRASIT PETPIBOON , ROY PATRICK
IPC: C07D333/06 , A61K31/12 , A61K31/122 , A61K31/34 , A61K31/341 , A61K31/343 , A61K31/38 , A61K31/381 , A61K31/404 , A61K31/4184 , A61K31/4196 , A61K31/425 , A61K31/429 , A61K31/433 , A61K31/435 , A61K31/4355 , A61K31/437 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/47 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/54 , A61P25/04 , A61P29/00 , A61P43/00 , C07C317/24 , C07D213/64 , C07D307/58 , C07D307/60 , C07D307/62 , C07D307/64 , C07D307/66 , C07D307/68 , C07D307/83 , C07D307/94 , C07D333/26 , C07D405/12 , C07D407/12 , C07D409/12 , C07D417/12 , C07D471/04 , C07D491/04 , C07D491/048 , C07D495/04 , C07D498/04 , C07D513/04 , A61K31/365
Abstract: The new compound with formula can be used in the treatment fo diseases caused by cyclooxygenase-2. The invention also relates to certain pharmaceutical compositions containing the above compounds. 45 claims
-
-
-
-
-
-
-
-
-